Electromed, Inc. (ELMD) |
|
10.17 0.1 (0.99%)
|
03-22 16:00 |
|
Open: |
10.06 |
Pre. Close: |
10.07 |
|
High:
|
10.73 |
Low:
|
10.06 |
|
Volume:
|
17,055 |
Market Cap:
|
87(M) |
|
|
|
Technical analysis |
as of: 2023-03-22 4:17:53 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 14.46 One year: 16.16 |
| Support: |
Support1: 10.03 Support2: 8.35 |
| Resistance: |
Resistance1: 12.38 Resistance2: 13.84 |
| Pivot: |
11.43  |
| Moving Average: |
MA(5): 10.22 MA(20): 11.91
MA(100): 10.84 MA(250): 10.81 |
| MACD: |
MACD(12,26): -0.6 Signal(9): -0.3 |
| Stochastic oscillator: |
%K(14,3): 1.7 %D(3): 2.6 |
| RSI: |
RSI(14): 30.6 |
| 52-week: |
High: 13.84 Low: 8.75 |
| Average Vol(K): |
3-Month: 14 (K) 10-Days: 21 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ELMD ] has closed above bottom band by 20.3%. Bollinger Bands are 200% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 24 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
10.67 - 10.77 |
10.77 - 10.83 |
|
Low:
|
9.86 - 9.99 |
9.99 - 10.07 |
|
Close:
|
9.92 - 10.13 |
10.13 - 10.26 |
|
Company Description |
|
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota. |
Headline News |
Wed, 15 Feb 2023
Electromed CEO Kathleen Skarvan is retiring - The Business Journals
Tue, 14 Feb 2023
Electromed, Inc. Announces Fiscal 2023 Second Quarter Results - Business Wire
Wed, 08 Feb 2023
Should Medical Devices Stock Electromed Inc (ELMD) Be in Your ... - InvestorsObserver
Wed, 08 Feb 2023
Cano Health Inc (CANO) Up 5.23% in Premarket Trading - InvestorsObserver
Tue, 31 Jan 2023
Electromed, Inc. Schedules its Second Quarter Fiscal 2023 Financial ... - Business Wire
Thu, 15 Dec 2022
10 Stocks Under $20 to Buy Now - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
9 (M) |
| Shares Float |
7 (M) |
|
% Held by Insiders
|
16.7 (%) |
|
% Held by Institutions
|
45.8 (%) |
|
Shares Short
|
50 (K) |
|
Shares Short P.Month
|
60 (K) |
Stock Financials |
|
EPS
|
0.25 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0.18 |
|
EPS Est Next Year
|
0.23 |
|
Book Value (p.s.)
|
3.85 |
|
Profit Margin (%)
|
6 |
|
Operating Margin (%)
|
7.9 |
|
Return on Assets (ttm)
|
5.2 |
|
Return on Equity (ttm)
|
7 |
|
Qtrly Rev. Growth
|
24.8 |
|
Gross Profit (p.s.)
|
3.18 |
|
Sales Per Share
|
4.4 |
|
EBITDA (p.s.)
|
0.42 |
|
Qtrly Earnings Growth
|
-16.8 |
|
Operating Cash Flow
|
2 (M) |
|
Levered Free Cash Flow
|
1 (M) |
Stock Valuations |
|
PE Ratio
|
38.96 |
|
PEG Ratio
|
2.7 |
|
Price to Book value
|
2.62 |
|
Price to Sales
|
2.29 |
|
Price to Cash Flow
|
51.67 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
